Literature DB >> 33498793

HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity.

Anne Kapaata1, Sheila N Balinda1, Rui Xu2, Maria G Salazar1, Kimberly Herard2, Kelsie Brooks2, Kato Laban1, Jonathan Hare3,4, Dario Dilernia2, Anatoli Kamali5, Eugene Ruzagira1, Freddie Mukasa1, Jill Gilmour3,4, Jesus F Salazar-Gonzalez1, Ling Yue2, Matthew Cotten1,6, Eric Hunter2, Pontiano Kaleebu1.   

Abstract

The ability to efficiently establish a new infection is a critical property for human immunodeficiency virus type 1 (HIV-1). Although the envelope protein of the virus plays an essential role in receptor binding and internalization of the infecting virus, the structural proteins, the polymerase and the assembly of new virions may also play a role in establishing and spreading viral infection in a new host. We examined Ugandan viruses from newly infected patients and focused on the contribution of the Gag-Pol genes to replication capacity. A panel of Gag-Pol sequences generated using single genome amplification from incident HIV-1 infections were cloned into a common HIV-1 NL4.3 pol/env backbone and the influence of Gag-Pol changes on replication capacity was monitored. Using a novel protein domain approach, we then documented diversity in the functional protein domains across the Gag-Pol region and identified differences in the Gag-p6 domain that were frequently associated with higher in vitro replication.

Entities:  

Keywords:  Gag-Pol; HIV-1; Uganda; protein domains; recombinant

Mesh:

Substances:

Year:  2021        PMID: 33498793      PMCID: PMC7912664          DOI: 10.3390/v13020171

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  52 in total

1.  Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.

Authors:  Marion W Kiguoya; Jaclyn K Mann; Denis Chopera; Kamini Gounder; Guinevere Q Lee; Peter W Hunt; Jeffrey N Martin; T Blake Ball; Joshua Kimani; Zabrina L Brumme; Mark A Brockman; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.

Authors:  Jared M Baeten; Bhavna Chohan; Ludo Lavreys; Vrasha Chohan; R Scott McClelland; Laura Certain; Kishorchandra Mandaliya; Walter Jaoko; Julie Overbaugh
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

3.  The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.

Authors:  Barbara Müller; Tilo Patschinsky; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.

Authors:  Awet Abraha; Immaculate L Nankya; Richard Gibson; Korey Demers; Denis M Tebit; Elizabeth Johnston; David Katzenstein; Asna Siddiqui; Carolina Herrera; Lucia Fischetti; Robin J Shattock; Eric J Arts
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 (HIV-1) circulating recombinant form 02_AG (CRF02_AG) has a higher in vitro replicative capacity than its parental subtypes A and G.

Authors:  Frank A J Konings; Sherri T Burda; Mateusz M Urbanski; Ping Zhong; Arthur Nadas; Phillipe N Nyambi
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327

6.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  jpHMM: improving the reliability of recombination prediction in HIV-1.

Authors:  Anne-Kathrin Schultz; Ming Zhang; Ingo Bulla; Thomas Leitner; Bette Korber; Burkhard Morgenstern; Mario Stanke
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

8.  Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers.

Authors:  Boyan Grigorov; Didier Décimo; Fatima Smagulova; Christine Péchoux; Marylène Mougel; Delphine Muriaux; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2007-08-03       Impact factor: 4.602

9.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

10.  The Pfam protein families database in 2019.

Authors:  Sara El-Gebali; Jaina Mistry; Alex Bateman; Sean R Eddy; Aurélien Luciani; Simon C Potter; Matloob Qureshi; Lorna J Richardson; Gustavo A Salazar; Alfredo Smart; Erik L L Sonnhammer; Layla Hirsh; Lisanna Paladin; Damiano Piovesan; Silvio C E Tosatto; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  1 in total

1.  A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells.

Authors:  Audrey E Rindler; Herbert Kuster; Kathrin Neumann; Christine Leemann; Dominique L Braun; Karin J Metzner; Huldrych F Günthard
Journal:  Viruses       Date:  2021-03-04       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.